acetaminophen has been researched along with Cytokine Release Syndrome in 2 studies
Acetaminophen: Analgesic antipyretic derivative of acetanilide. It has weak anti-inflammatory properties and is used as a common analgesic, but may cause liver, blood cell, and kidney damage.
paracetamol : A member of the class of phenols that is 4-aminophenol in which one of the hydrogens attached to the amino group has been replaced by an acetyl group.
Cytokine Release Syndrome: A severe immune reaction characterized by excessive release of CYTOKINES. Symptoms include DYSPNEA; FEVER; HEADACHE; HYPOTENSION; NAUSEA; RASH; TACHYCARDIA; HYPOXIA; HYPERFERRITINEMIA, and MULTIPLE ORGAN FAILURE. It is associated with viral infections, SEPSIS; AUTOIMMUNE DISEASES and a variety of factors used in IMMUNOTHERAPY.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Mahmood Alam, J | 1 |
Asghar, SS | 1 |
Ali, H | 1 |
Mahmood, SR | 1 |
Ansari, MA | 1 |
Della-Torre, E | 1 |
Della-Torre, F | 1 |
Kusanovic, M | 1 |
Scotti, R | 1 |
Ramirez, GA | 1 |
Dagna, L | 1 |
Tresoldi, M | 1 |
2 other studies available for acetaminophen and Cytokine Release Syndrome
Article | Year |
---|---|
REPORT- Varying pattern of blood gases, ferritin, procalcitonin, C-Reactive protein, interleukin 6 and lactate dehydrogenase in Covid-19 patients suffering from diverse Co-Morbid, suspected cytokine storm and periodic effects of antiviral and steroidal tr
Topics: Acetaminophen; Antipyretics; Antiviral Agents; Biomarkers; Blood Gas Analysis; C-Reactive Protein; C | 2021 |
Treating COVID-19 with colchicine in community healthcare setting.
Topics: Acetaminophen; Anti-Inflammatory Agents; Azithromycin; Betacoronavirus; Cohort Studies; Colchicine; | 2020 |